1
|
Mezzatesta ML, Gona F and Stefani S:
Enterobacter cloacae complex: Clinical impact and emerging
antibiotic resistance. Future Microbiol. 7:887–902. 2012.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Xiao YH, Shen P, Wei ZQ, Chen YB, Kong HS,
Yang Q, Zhang WL, Chen X and Li LJ: Mohnarin report of 2011:
Monitoring of bacterial resistance in China. Zhong Hua Yi Yuan Gan
Ran Xue Za Zhi. 22:4946–4952. 2012.(In Chinese).
|
3
|
Bradford PA: Extended-spectrum
beta-lactamases in the 21st century: Characterization, epidemiology
and detection of this important resistance threat. Clin Microbiol
Rev. 14:933–951. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hawkey PM: Prevalence and clonality of
extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect.
14(Suppl 1): 159–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chia JH, Chu C, Su LH, Chiu CH, Kuo AJ,
Sun CF and Wu TL: Development of a multiplex PCR and SHV
melting-curve mutation detection system for detection of some SHV
and CTX-M beta-lactamases of Escherichia coli, Klebsiella
pneumoniae and Enterobacter cloacae in Taiwan. J Clin
Microbiol. 43:4486–4491. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Newire EA, Ahmed SF, House B, Valiente E
and Pimentel G: Detection of new SHV-12, SHV-5 and SHV-2a variants
of extended spectrum beta-lactamase in Klebsiella pneumoniae
in Egypt. Ann Clin Microbiol Antimicrob. 12:162013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Juhász E, Jánvári L, Tóth A, Damjanova I,
Nobilis A and Kristóf K: Emergence of VIM-4- and SHV-12-producing
Enterobacter cloacae in a neonatal intensive care unit. Int
J Med Microbiol. 302:257–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tansawai U, Boonkerd N, Polwichai P,
Dejsirilert S and Niumsup PR: SHV-12 extended spectrum
beta-lactamase associated with high-level ceftazidime resistance in
Enterobacter cloacae isolated from Thailand. Southeast Asian
J Trop Med Public Health. 40:148–154. 2009.PubMed/NCBI
|
9
|
Lee CH, Su LH, Li CC, Chien CC, Tang YF
and Liu JW: Microbiologic and clinical implications of bacteremia
due to extended-spectrum-beta-lactamase-producing Klebsiella
pneumoniae with or without plasmid-mediated AmpC beta-lactamase
DHA-1. Antimicrob Agents Chemother. 54:5395–5398. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lee CC, Lee NY, Yan JJ, Lee HC, Chen PL,
Chang CM, Wu CJ, Ko NY, Wang LR, Chi CH and Ko WC: Bacteremia due
to extended spectrum-beta-lactamase-producing Enterobacter
cloacae: Role of carbapenem therapy. Antimicrob Agents
Chemother. 54:3551–3556. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Liu CP, Wang NY, Lee CM, Weng LC, Tseng
HK, Liu CW, Chiang CS and Huang FY: Nosocomial and
community-acquired Enterobacter cloacae bloodstream
infection: Risk factors for and prevalence of SHV-12 in
multiresistant isolates in a medical centre. J Hosp Infect.
58:63–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rodríguez-Baño J, Miró E, Villar M, Coelho
A, Gozalo M, Borrell N, Bou G, Conejo MC, Pomar V, Aracil B, et al:
Colonisation and infection due to Enterobacteriaceae producing
plasmid-mediated AmpC β-lactamases. J Infect. 64:176–183. 2012.
View Article : Google Scholar : PubMed/NCBI
|
13
|
CLSI: Performance Standards for
Antimicrobial Susceptibility Testing; Twenty-Second Informational
Supplement. CLSI document M100-S22. Clinical and Laboratory
Standards Institute. (Wayne, PA). 2013.
|
14
|
Ni YX: Plasmid annihilation. Basic and
Clinical Microbial Drug Resistance. Zhang ZR, Xia MY and Ni YX:
(Beijing). People's Medical Publishing House. 240–242. 2006.
|
15
|
Stumpf AN, Roggenkamp A and Hoffmann H:
Specificity of Enterobacterial repetitive intergenic consensus and
repetitive extragenic palindromic polymerase chain reaction for the
detection of clonality within the Enterobacter cloacae
complex. Diagn Microbiol Infect Dis. 53:9–16. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Biendo M, Manoliu C, Laurans G, Castelain
S, Canarelli B, Thomas D, Hamdad F, Rousseau F and Eb F: Molecular
typing and characterization of extended-spectrum TEM, SHV and CTX-M
beta-lactamases in clinical isolates of Enterobacter
cloacae. Res Microbiol. 159:590–594. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lahlaoui H, Anis BH, Mohamed K and Mohamed
BM: Emergence of SHV-12 extended spectrum beta-lactamase among
clinical isolates of Enterobacter cloacae in Tunisia. Microb
Pathog. 53:64–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Miró E, Segura C, Navarro F, Sorlí L, Coll
P, Horcajada JP, Alvarez-Lerma F and Salvadó M: Spread of plasmids
containing the bla(VIM-1) and bla(CTX-M) genes and the qnr
determinant in Enterobacter cloacae, Klebsiella
pneumoniae and Klebsiella oxytoca isolates. J Antimicrob
Chemother. 65:661–665. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Liu J, Li GM, Zhao Y, Hu XH, Yang WQ and
Yang JR: Study on the resistance genes of avriable region of class
I integron in Enterobacter cloacae. Zhong Guo Kang Sheng Su
Za Zhi. 36:543–547. 2011.(In Chinese).
|
20
|
Liu J, Li GM, Zhao Y, Hu XH, Yang WQ and
Yang JR: Correlation among integron positioning, ESBL-production
and resistance in Enterobacter cloacae. Guang Dong Yi Xue.
32:195–198. 2011.(In Chinese).
|
21
|
Ko KS, Lee MY, Song JH, Lee H, Jung DS,
Jung SI, Kim SW, Chang HH, Yeom JS, Kim YS, et al: Prevalence and
characterization of extended-spectrum beta-lactamase-producing
Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol
Infect Dis. 61:453–459. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Garza-González E, Mendoza Ibarra SI,
Llaca-Díaz JM and Gonzalez GM: Molecular characterization and
antimicrobial susceptibility of extended-spectrum
{beta}-lactamase-producing Enterobacteriaceae isolates at a
tertiary-care centre in Monterrey, Mexico. J Med Microbiol.
60:84–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Chen CH and Huang CC: Risk factor analysis
for extended-spectrum β-lactamase-producing Enterobacter
cloacae bloodstream infections in central Taiwan. BMC Infect
Dis. 13:4172013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Sharma J, Sharma M and Ray P: Detection of
TEM & SHV genes in Escherichia coli & Klebsiella
pneumoniae isolates in a tertiary care hospital from India.
Indian J Med Res. 132:332–336. 2010.PubMed/NCBI
|
25
|
Nogueira Kda S, Paganini MC, Conte A, Cogo
LL, de Messias Taborda Reason I, da Silva MJ and Dalla-Costa LM:
Emergence of extended-spectrum β-lactamase producing
Enterobacter spp. in patients with bacteremia in a tertiary
hospital in southern Brazil. Enferm Infecc Microbiol Clin.
32:87–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yan JJ, Ko WC, Chuang CL and Wu JJ:
Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a
university hospital in Taiwan: Prevalence of IMP-8 in
Enterobacter cloacae and first identification of VIM-2 in
Citrobacter freundii. J Antimicrob Chemother. 50:503–511.
2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu G, Ling BD, Zeng Y, Lin L, Xie YE and
Lei J: Molecular characterization of extended-spectrum
beta-lactamases produced by clinical isolates of Enterobacter
cloacae from a teaching hospital in China. Jpn J Infect Dis.
61:286–289. 2008.PubMed/NCBI
|
28
|
Biendo M, Manoliu C, Laurans G, Castelain
S, Canarelli B, Thomas D, Hamdad F, Rousseau F and Eb F: Molecular
typing and characterization of extended-spectrum TEM, SHV and CTX-M
beta-lactamases in clinical isolates of Enterobacter
cloacae. Res Microbiol. 159:590–594. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Machado E, Ferreira J, Novais A, Peixe L,
Cantón R, Baquero F and Coque TM: Preservation of integron types
among Enterobacteriaceae producing extended-spectrum
beta-lactamases in a Spanish hospital over a 15-year period (1988
to 2003). Antimicrob Agents Chemother. 51:2201–2204. 2007.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Novak A, Goic-Barisic I, Andrasevic AT,
Butic I, Radic M, Jelic M, Rubic Z and Tonkic M: Monoclonal
outbreak of VIM-1-carbapenemase-producing Enterobacter
cloacae in intensive care unit, University Hospital Centre
Split, Croatia. Microb Drug Resist. 20:399–403. 2014. View Article : Google Scholar : PubMed/NCBI
|